Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (191-200 of 412) with videos related to

Pageof 42
Sort By:
JAMA Oncology|November 13, 2015
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung CancerJoseph McLaughlin, Gang Han, Kurt A Schalper, et al.
JAMA Oncology|August 20, 2016
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1Patricia Gaule, James W Smithy, Maria Toki, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2016
Early and multiple origins of metastatic lineages within primary tumorsZi-Ming Zhao, Bixiao Zhao, Yalai Bai, et al.
Cancer|May 13, 2004
beta-Catenin and p53 analyses of a breast carcinoma tissue microarrayGina G Chung, Maciej P Zerkowski, Idris Tolgay Ocal, et al.
Diabetes|February 11, 2011
Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucoseEitan M Akirav, Maria-Teresa Baquero, Lynn W Opare-Addo, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2013
A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cellsHollis Viray, Kevin Li, Thomas A Long, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2019
Immune Checkpoint Inhibitor-Associated PericarditisMehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Frontiers in Oncology|September 16, 2021
High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior PrognosisPhilippa Li, Ji Yuan, Fahad Shabbir Ahmed, et al.
Nature Methods|September 6, 2016
A proposal for validation of antibodiesMathias Uhlen, Anita Bandrowski, Steven Carr, et al.
Cancer Research|March 5, 2003
Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancerJung Y Kang, Marisa Dolled-Filhart, Idris Tolgay Ocal, et al.
Pageof 42

Showing results (191-200 of 412) with videos related to

Sort By:
Pageof 42
JAMA Oncology|November 13, 2015
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung CancerJoseph McLaughlin, Gang Han, Kurt A Schalper, et al.
JAMA Oncology|August 20, 2016
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1Patricia Gaule, James W Smithy, Maria Toki, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 10, 2016
Early and multiple origins of metastatic lineages within primary tumorsZi-Ming Zhao, Bixiao Zhao, Yalai Bai, et al.
Cancer|May 13, 2004
beta-Catenin and p53 analyses of a breast carcinoma tissue microarrayGina G Chung, Maciej P Zerkowski, Idris Tolgay Ocal, et al.
Diabetes|February 11, 2011
Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: control of islet vasculature and vascular endothelial growth factor by glucoseEitan M Akirav, Maria-Teresa Baquero, Lynn W Opare-Addo, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2013
A prospective, multi-institutional diagnostic trial to determine pathologist accuracy in estimation of percentage of malignant cellsHollis Viray, Kevin Li, Thomas A Long, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2019
Immune Checkpoint Inhibitor-Associated PericarditisMehmet Altan, Maria I Toki, Scott N Gettinger, et al.
Frontiers in Oncology|September 16, 2021
High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior PrognosisPhilippa Li, Ji Yuan, Fahad Shabbir Ahmed, et al.
Nature Methods|September 6, 2016
A proposal for validation of antibodiesMathias Uhlen, Anita Bandrowski, Steven Carr, et al.
Cancer Research|March 5, 2003
Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancerJung Y Kang, Marisa Dolled-Filhart, Idris Tolgay Ocal, et al.
Pageof 42